U.S. Markets closed

Acceleron: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Acceleron Pharma Inc. (XLRN) on Thursday reported a loss of $38.1 million in its first quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 74 cents.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.

The clinical stage biotech developing protein therapeutics for cancer and rare diseases posted revenue of $2.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $3.7 million.

Acceleron shares have fallen almost 5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $41.51, an increase of 15% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XLRN at https://www.zacks.com/ap/XLRN